The aim of this study was to investigate the infl uence of prebiotic inulin diet intervention on the activity of β-glucuronidase and counts of coliforms and lactobacilli in fresh caecal digesta, cytokine levels (IL-6, IL-8) and transcription nuclear factor kappa beta (NFkB) activities in the colon tissue and blood samples of rats with dextran sulphate sodium (DSS) induced acute colitis. Male Sprague-Dawley rats (8 per group) were randomly divided into three groups: Control, Acute colitis and Prebiotic. Colitis was induced using 5% DSS in drinking water for 7d. DSS application signifi cantly increased the activity of β-glucuronidase (p<0.001), increased counts of coliform bacteria and decreased lactobacilli count (p<0.05) in comparison to the control group. Serum and tissue levels of IL-6 and IL-8 as well as tissue NFkB activities showed an increased expression in the acute colitis group. These results correspond to the average value of the disease activity index score (DAI) and revealed the maximum DAI score (6.5) in the acute colitis group. A decrease in the DAI score (4.13) was observed after application of the prebiotic inulin. Inulin diet intervention positively modifi ed the number of microorganims and decreased β-glucuronidase activity. Colon tissue activities of NFkB were signifi cantly suppressed (p<0.001). The synthesis of proinfl ammatory cytokines IL-6 (p<0.01) in the serum and in the colon tissue, as well as tissue in the prebiotic group were downregulated. These fi ndings indicate that the dietary intake of inulin suppressed the expression of the observed markers, which play an important role in the infl ammatory process, which predisposes to the use of inulin in the prevention or treatment of acute colitis in human and veterinary medicine.
INTRODUCTION
Infl ammatory bowel diseases (IBD) are well known gastrointestinal disorders in humans; however, similar disorders are also present and often investigated in several animal species [1] . As a nosological unit within infl ammatory bowel diseases ulcerative colitis (Colitis ulcerosa -CU) is a chronic, nonspecifi c relapsing disease characterised by diffuse mucosal infl ammation limited to the colon. It is a serious medical and socio-economic problem with an increasing incidence and prevalence in humans. The aetiology of ulcerative colitis is not yet understood. Failure of immunoregulatory mechanisms due to external environmental factors in genetically predisposed individuals suggests the current concept of the pathophysiology of infl ammatory diseases. The course of CU is characterized by an impact frequency of unpredictable occurrence of relapse (acute infl ammation) and remission (infl ammation in decline). In genetically susceptible individuals, an abnormal communication between the intestinal microbial fl ora and mucosal immune system forms the basis of the defect, which is accompanied by mucosal infl ammatory lesions of the gastrointestinal tract. Studies on animal models of colitis indicated that dysregulation of host/microbial interactions, which included the loss of epithelial and cell barrier functions, were the pre-requisite for the development of IBD [2, 3] . Risk factors for colorectal carcinoma development in CU include the duration of the disease, early age of onset, family history of sporadic colorectal carcinoma, and persistent infl ammation of the colon [4] . Patients with long-standing CU have a higher risk of developing colitis-associated cancer (CAC) approximately 8-10 years after the initial diagnosis when compared to the general population [5] . In addition to genomic instability that underlies the process of tumorigenesis, continuous infl ammation in the intestine seems to be a key factor in CAC development since chronic infl ammation is associated with an overexpression of proinfl ammatory cytokines, chemokines, growth factors as well as their receptors, and reactive oxygen species [6, 7] .
A high morbidity, signifi cant early and late complications, and decreased quality of life are the reason for seeking new possibilities for the prevention, rational diagnosis and treatment. It has been suggested that modifying the bacterial fl ora with probiotics and prebiotics may attenuate the infl ammatory process and prevent relapses and maintenance of remission in ulcerative colitis [8] .
The goal of the presented study was to obtain informations about the effects of the prebiotic inulin on the activity of β-glucuronidase and on the counts of coliforms and lactobacilli in fresh caecal digesta, cytokine levels (IL-6, IL-8), and transcription nuclear factor kappa beta (NFkB) activities in colon tissue and blood samples of rats with dextran sulphate sodium (DSS) induced acute colitis.
MATERIAL AND METHODS

Animals and experimental design
All animals in the experiment were kept in accordance with the principles outlined in The rats were randomly assigned to the following groups: Control (control group) received the conventional feed (Snina, Slovak Republic) for 14 days, Acute colitis (acute colitis group) received conventional feed without DSS for 7 days followed by 7 days of feed with DSS, and Prebiotic (acute colitis + prebiotic) group received conventional feed supplemented with prebiotic inulin (BeneoSynergy 1, ORAFTI, Tienen, Belgium) at a dose of 80g/kg feed without DSS for a period of 7 days, followed by 7 days of the same feed with DSS.
All animals had free access to water and feed. Animal weights and clinical monitoring of the health status were recorded daily. After 14 days of consuming the experimental diets, the animals were euthanized under anesthesia (Zoletil, Virbac S.A., France) administered at a dose of 50mg/kg body weight with Xylazin (Riemser, Germany) at a dose of 15 mg/kg body weight, intramuscular). Blood samples were taken by cardiac puncture. Caecal and tissue samples from the colon were recovered for microbial, biochemical and immunological analysis.
Induction of colitis
Colitis was induced using DSS (molecular weight 40 000, TdB Consulting AB, Uppsala, Sweden) added to drinking water at a fi nal concentration of 5% (wt/vol) for 7d. Controls were all time-matched and consisted of rats receiving normal drinking water only. The DSS solution was replenished daily and mean DSS consumption was noted per cage at the end of 7d treatment.
Disease activity index
Disease activity index (DAI) is the combined score of animal weight loss, stool consistency and bleeding present in the stool as described in Table 1 . Stool probes were tested to evaluate rectal bleeding by using HemoFEC test (Roche Diagnostics, Slovak Republic). All parameters were assessed on a scale from 0 to 3, or 4, the maximum score was 10. These parameters were each assigned a score and utilized to calculate an average daily disease activity index score for each rat as previously described [9] . ) were made with the same sterile diluent. From each dilution, 0.1 mL aliquots were spread onto selective McConkey agar plates (Merck, Germany) for coliforms and Rogosa agar plates (Biokar Diagnostics, France) for lactobacilli. The plates for lactobacilli culturing were maintained under anaerobic conditions (BD GasPak, Becton, Dickinson and Company, USA) and incubated at 37ºC for 48 h. Plates used for coliform culturing were incubated aerobically at 37ºC for 16-18 h. The numbers of colony forming units (CFU) are expressed as log 10 CFU per gram of feces.
Measurement of caecal β-glucuronidase activity
The activity of β -glucuronidase (β-GLUCUR) bacterial enzyme was measured in fresh caecal digesta taken after completion of the experiment by determining the rate of p-or o-nitrophenol as previously described by Juskiewicz et al. [10] . The reaction contained 0.3 mL of substrate solution (5 mM) p-nitrophenyl-β-D-glucuronide for β-glucuronidase (Sigma Aldrich, USA) and 0.2 mL of 1:10 (v/v) dilution of the caecal digesta in 100 mM phosphate buffer (pH 7.0) centrifuged at 10,000 g for 15 min at 4ºC. Incubation was carried out at 37ºC for 10 min, and p-or o-nitrophenol was quantifi ed after addition of 0.25 M cold sodium carbonate. Absorbtion was measured at 400 nm. Enzymatic activity is expressed as μmol of p-nitrophenol per min per gram digesta.
Cytokine levels (IL-6, IL-8), and NFkB in serum and colon homogenates
Blood samples were left to clot for two hours at room temperature before centrifugation for 15 mimutes at 1000xg. The removed serum samples were stored at -20ºC. Colon tissue samples were rinsed in ice cold PBS (pH 7.0-7.2) to remove excess blood thoroughly, cut longitudinally and homogenized in PBS with a homogenizer on ice (Disperser T10 Basic Ultra Turrax, Germany) and stored overnight at -20ºC. Thereon two freeze-thaw cycles were performed to break the cell membranes. After that the homogenates were centrifuged for 5 min at 5000xg at 2 -8ºC, the supernatant was removed and stored at -20ºC. All enpoints were measured by ELISA method as follows: NFkB in tissue by USCN Life Science, Inc., USA; IL-6 in blood and tissue by eBioscience, USA; IL-8 in tissue by Cusabio Biotech Co., Ltd. China. The fi nal values of each parameter were measured on Synergy H4 multiplate reader (BioTek Instruments, Inc. USA).
Statistical analysis
Results are expressed as mean ± standard deviation (SD). Statistical analysis was performed using analysis of variance (ANOVA) with p values (p<0.05) considered to be statistically signifi cant.
RESULTS
During the experimental trial, the clinical changes observed in rats did not lead to death. The mean body weight of the rats at the beginning of the experiment and at the end of the experiment in the control group increased by 30.92% (242.50 g ± 22.69 g vs. 317.50 g ± 21.69 g), in acute colitis by 9.90% (252.50 g ± 10.90 g vs 277.5 g ± 20.72 g), in acute colitis combined with the prebiotic by 14.28% (253.75 g ± 21.76 g vs 290.0 g ± 27.08 g). The average value of all daily disease activity index score showed that the maximum DAI score (6.5) was in the acute colitis group in comparison to the control group (0.3). A DAI score decline was observed after application of the prebiotic (4.13). The applied DSS signifi cantly increased the activity of β-glucuronidase (p<0.001) in comparison to the control group and applied prebiotic non-signifi cantly decreased the activity of this enzyme as shown Table 2 . Changes of total counts of coliforms and lactobacilli in different experimental groups are summarized in Table 2 . In Table 3 are shown changes in cytokines levels and NFkB activities in the serum (s) and tissue (t) in the control group, acute colitis group and in the prebiotic treated group.
DISCUSSION
Infl ammatory bowel disease (IBD) is a group of chronic infl ammatory disorders that affects individuals throughout life. The role of interactions between genetic, immunologic, microbial and environmental factors is expected in UC, but the exact etiology and pathogenesis still remains unclear. Long-standing UC has an increased risk of developing CAC/CRC (colon carcinogenesis) [11] . It is also widely accepted that chronic infl ammation promotes carcinogenesis by inducing the production of a variety of cytokines and chemokines that propagate a localized infl ammatory response by activating transcription factors such as NF-kB which is accompanied by increased COX-2, iNOS and pro-infl ammatory cytokines. These fi ndings have important implications for the possible development of anticancer treatments and offer an opportunity to devise strategies that supports the opinion that probiotics and prebiotics can provide an alternative or adjuvant approach to conventional therapy by modulating the intestinal microfl ora and host immune system. The goal of this study was to obtain information about the effect of a diet with added inulin in DSS-induced acute colitis rat model.
Prebiotics are a family of molecules which meet the classifi cation criteria for being considered a prebiotic, as defi ned Gibson and Roberfroid [12] ; i.e. resistance to hydrolysis or absorption in the upper gastrointestinal tract, fermentation by the intestinal microbiota, and selective stimulation of growth and/or activity of benefi cial intestinal bacteria, such as Lactobacillus species and Bifi dobacterium species which have a positive impact on the health of the host [13] [14] [15] .
In our study DSS-induced acute colitis increased (not signifi cantly) the number of coliforms and signifi cantly (p<0.05) decreased the number of lactobacilli in the acute colitis group in comparison with the control group. Within a short experimental period inulin dietary supplementation positively modifi ed the values observed for microorganisms and activity of β-glucuronidase. Unlike for lactobacilli and coliforms, the activity of β-GLUCUR is believed to be a biomarker of neoplasms and is also perceived as harmful due to the associated release of carcinogens from hepatically derived glucuronic acid conjugates. β-GLUCUR was signifi cantly increased (p<0.001) in the acute colitis group.
Chronic infl ammation is known to lead to the derangement in signaling processes and to a local microenvironment described as lying somewhere between pre-cancerous stromal cells and cancer cells, even as the details of the steps in the transformation to cancer cells are incompletely understood [16] . In the signaling pathways involved in colonic infl ammation NFkB plays a key role. NFkB regulates the expression of various cytokines and modulates the infl ammatory processes characteristic of IBD [17] . Further, NFkB controls apoptosis, cell-cycle progression, cell proliferation, and differentiation. Although NFkB activation has been shown to be involved in CRC development, normally functioning NFkB is essential for the maintenance of epithelial cell homeostasis in the gut. Translocation of activated NFkB into the nucleus induces the expression of cytokines such as TNFα and IL-6, and chemokines, all of which contribute to the development of infl ammation-related tissue damage. Cilj ovog rada bio je da se ispita uticaj dijetarne intervencije sa prebiotikom inulinom na aktivnost β-glukuronidaze i broja koliformnih bakterija i laktobacila u svežem sadržaju cekuma, nivoa citokina (IL-6 i IL-8) i aktivnosti transkripcionog nuklearnog faktora kapa beta (NFkB) u tkivu kolona i uzorcima krvi pacova sa kolitisom indukovanim dekstran-sulfat natrijumom (DSS). Muški Sprague-Dawley pacovi (8 u grupi) su bili nasumično raspoređeni u tri grupe: kontrolna, akutni kolitis i prebiotik grupa. Kolitis je indukovan pomoću 5% DSS u pijaćoj vodi tokom 7 dana. Dodavanje DSSa je signifi kantno povećalo aktivnost β-glukuronidaze (p<0,001), povećalo broj koliformnih bakterija i smanjilo broj laktobakcila (p<0,05) u poređenju sa kontrolnom grupom. Serumski i tkivni nivoi IL-6 i IL-8, kao i tkivna NFkB aktivnost su pokazali povećanu ekspresiju u grupi sa akutnim kolitisom. Ovi rezultati odgovaraju prosečnim vrednostima indeksa aktivnosti bolesti (DAI) i pokazali su da su maksimalne vrednosti DAI bodovanja (6,5) postignute u grupi sa akutnim kolitisom. Smanjenje DAI vrednosti (4,13) je uočeno nakon aplikacije prebiotika inulina. Dijetarna intervencija inulinom pozitivno je modifi kovala broj mikroorganizama i smanjila aktivnost β-glukuronidaze.
